Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir Biotechnology, Inc. (NASDAQ:VIR) announced that the first patient had been dosed in one ...

BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector ...

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

Virtual event highlights cutting‑edge innovations driving advances in healthcare, sustainability, and emerging ...

Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...

The full picture of Replimune's layoffs is coming into focus — and more employees are on the chopping block than previously ...

Food technology and ingredients company Kerry Group has opened its expanded biotechnology manufacturing facility in Carrigaline in Co Cork, significantly increasing its capacity to produce lactase ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will ...

April 20, 2026) – Huxley Health Inc. (“Huxley” or the “Company”), together with its Aerasyn Biotech division, a biotechnology platform advancing next-generation therapeutics through AI-guided ...

With a market cap of $26 billion, Biogen Inc. (BIIB) is a global biotechnology company that discovers, develops, and delivers ...

With a market cap of $191.8 billion, Amgen Inc. (AMGN) is a global biotechnology company that discovers, develops, ...

Eli Lilly has agreed to acquire Kelonia Therapeutics for up to $7 billion, in a deal that would bolster the buyer’s oncology ...